Actionable news
All posts from Actionable news
Actionable news in ALNY: Alnylam Pharmaceuticals, Inc.,

Alnylam Up 2.0% on Phase 1 Initiation of OLE Study with ALT-AT3

XBI Underperforms Compared to Broader Market on October 8

(Continued from Prior Part)

Top ten mid-cap stocks return an average of -0.5%

Considering the market cap, the top ten mid-cap stocks of the SPDR S&P Biotech ETF (XBI) gave an average return of -0.5% compared to 0.9% for the SPDR S&P 500 ETF (SPY) on October 8, 2015. The top ten stocks include Alkermes (ALKS), United Therapeutics (UTHR), and Seattle Genetics (SGEN), which returned -0.13%, 2%, and...